Except for sex and ECOG-PS, all clinical features were comparable between N-DLBCL and EN-DLBCL patients, including age, B symptoms, pathological classification and international prognostic index (IPI) score, bulky disease, Ki-67 and lactate dehydrogenase (LDH). This evidence concerns the gene MKI67 and diffuse large B-cell lymphoma.